Abbott to Present New Clinical Data on Current and Future Innovations in Interventional Cardiology at EuroPCR 2010
May 20, 2010
May 20, 2010
ABBOTT PARK, Ill., May 20 -- Abbott Laboratories issued the following news release:
Abbott today announced the company's schedule of key news announcements and events during the EuroPCR 2010 conference in Paris, May 25 - 28. Highlights include four late-breaking clinical trial presentations on Abbott's broad portfolio of vascular devices. The late-breaking presentations will include new data on the company's market-leading XIENCE V (R) Everolimus Eluting Coronary Stent System, the . . .
Abbott today announced the company's schedule of key news announcements and events during the EuroPCR 2010 conference in Paris, May 25 - 28. Highlights include four late-breaking clinical trial presentations on Abbott's broad portfolio of vascular devices. The late-breaking presentations will include new data on the company's market-leading XIENCE V (R) Everolimus Eluting Coronary Stent System, the . . .